Maison Solutions MSS 深 滬
已收盤 09-19 16:00:00 美东时间
0.9439
-0.036
-3.68%
華盛通- 最 高0.978
- 今 開0.96
- 成交量 4.96万股
- 最 低 0.9439
- 昨 收 0.98
- 總市值 1858.59万
- 52周最高 2.08
- 市盈率 靜 14.32
- 換手率 0.25%
- 52周最低 0.8003
- 委 比 -74.20%
- 總股本 1969.05万
- 歷史最高 22.97
- 量 比 0.19
- 振 幅 3.48%
- 歷史最低 0.6005
- 每 手 1
- 風險率 0.16%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅432.99%！维持"投机性买入"评级，Unicycive Therapeutics获机构升目标价至21美元
今日重点评级关注：Benchmark：维持Unicycive Therapeutics"投机性买入"评级，目标价从3美元升至21美元；Guggenheim：维持Amylyx Pharmaceuticals"买入"评级，目标价从17美元升至25美元
09-16 09:48
Maison Solutions Inc. Delays 10-Q Filing
Maison Solutions Inc. Class A ( ($MSS) ) has released a notification of late fi...
09-16 04:18
Maison Solutions Inc. Secures $5.25 Million Loan
Maison Solutions Inc. Class A ( ($MSS) ) just unveiled an announcement. On Sept...
09-11 03:28
Agenus Says Investigational Combination BOT/BAL Now Available To Eligible Patients With Refractory MSS mCRC Under France's Compassionate Access Framework
Agenus Inc. (NASDAQ:AGEN), a leader in immuno‑oncology, today announced its investigational combination botensilimab plus balstilimab (BOT/BAL) is now available to eligible patients with refractory microsatellite‑stable
09-09 19:45
Maison Solutions Inc. Updates CEO and CFO Salaries
Maison Solutions Inc. Class A ( ($MSS) ) has shared an update. On August 28, 20...
08-29 04:52
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Aug. 28, 2025 /PRNewswire/ -- Federal budget cuts have put pressure on cancer research efforts in th...
08-28 22:44
